HSBC Holdings’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

HSBC Holdings’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-442,815	Closed	-$17.1M	–	2922
2023 Q2	$17.1M	Buy	+442,815	New	+$11.4M	0.02%	662
2018 Q4	–	Sell	-22,191	Closed	-$816K	–	2758
2018 Q3	$816K	Buy	+22,191	New	+$712K	﹤0.01%	1830

HSBC Holdings's KDNY Position: Q3 2023 in Review

HSBC Holdings sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 442,815 shares — an estimated $17.1M sold.

HSBC Holdings first reported a position in KDNY in Q3 2018 and held it in 2 quarters. The position peaked at $17.1M in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

HSBC Holdings reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
HSBC Holdings sold 442,815 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $17.1M.
HSBC Holdings first reported a position in Chinook Therapeutics, Inc. Common Stock in Q3 2018 and held it in 2 quarters.
HSBC Holdings's Chinook Therapeutics, Inc. Common Stock position peaked at $17.1M in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on HSBC Holdings's 13F filing for Q3 2023, filed 13 Nov 2023.